Effect of Moisturizer on Malaysian Women Facial Skin
The Effect of Product X Moisturizer on Skin Texture of Middle-Aged Women in Malaysia
1 other identifier
interventional
28
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effect of Product X on facial skin of middle-aged women in Malaysia. The main questions it aims to answer are:
- 1.The effect of Product X on skin hydration of middle-aged women in Malaysia.
- 2.The effect of Product X on skin elasticity of middle-aged women in Malaysia.
- 3.The effect of Product X on skin wrinkle of middle-aged women in Malaysia.
- 4.To observe any adverse effect occurrence with the use of Product X.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Aug 2022
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2022
CompletedFirst Submitted
Initial submission to the registry
December 7, 2022
CompletedFirst Posted
Study publicly available on registry
December 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedNovember 29, 2023
November 1, 2023
1.1 years
December 7, 2022
November 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in skin hydration from baseline and at week 2, 4 and 8 after using Product X
Skin hydration will be assessed using JANUS III skin analyzer
Baseline, week 2, 4 and 8
Change in skin elasticity from baseline and at week 2, 4 and 8 after using Product X
Skin elasticity will be assessed using JANUS III skin analyzer
Baseline, week 2, 4 and 8
Change in skin wrinkles from baseline and at week 2, 4 and 8 after using Product X
Skin wrinkles will be assessed using JANUS III skin analyzer and Wrinkle Severity Rating Scale (WSRS). For WSRS, dermatologists will evaluate participants' wrinkles based on 5-point photonumeric rating scale that will objectively evaluate the severity of crow's feet at rest (static) and with a smiling expression (dynamic). The scale scores are 0 for no wrinkles, 1 for very fine wrinkles, 2 for fine wrinkles, 3 for moderate wrinkles, and 4 for severe wrinkles.
Baseline, week 2, 4 and 8
Adverse effect after using Product X
Based on adverse effect occurrence on participants that occur during study period (8 weeks)
Week 8
Study Arms (1)
Product X moisturizer
EXPERIMENTALParticipants will used Product X moisturizer twice daily for 8 weeks
Interventions
Product X moisturizer containing Hyaluronic Acid and Rosa Damascena Flower Water
Eligibility Criteria
You may qualify if:
- Malaysian citizen
- Middle-aged woman (40-60 years old)
You may not qualify if:
- Participants taking isotretinoin
- Immunocompromised patients or participants with any skin diseases or diseases that may compromised the participants well-being and study outcome.
- Participant who undergo any cosmetic procedures such as laser \& light treatment for the past three months.
- Participant with a history of facial surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Petaling Jaya, Selangor, 47810, Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2022
First Posted
December 20, 2022
Study Start
August 15, 2022
Primary Completion
September 30, 2023
Study Completion
September 30, 2023
Last Updated
November 29, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share